Loading...
XNYS
DVA
Market cap8.29bUSD
Dec 05, Last price  
117.39USD
1D
0.09%
1Q
-14.85%
Jan 2017
82.85%
Name

DaVita Inc

Chart & Performance

D1W1MN
XNYS:DVA chart
P/E
8.85
P/S
0.65
EPS
13.26
Div Yield, %
Shrs. gr., 5y
-10.71%
Rev. gr., 5y
2.39%
Revenues
12.82b
+5.56%
2,973,918,0004,880,662,0005,264,151,0005,660,173,0006,108,800,0006,447,391,0006,791,980,0008,186,280,00011,764,050,00012,795,106,00013,781,837,00014,745,105,00010,876,634,00011,404,851,00011,388,479,00011,550,604,00011,618,797,00011,609,894,00012,140,147,00012,815,550,000
Net income
936m
+35.40%
228,643,000289,691,000381,778,000374,160,000422,684,000405,683,000478,001,000536,017,000633,446,000723,114,000269,732,000879,874,000663,618,000790,078,000810,981,000773,642,000978,450,000768,191,000691,535,000936,342,000
CFO
2.02b
-1.80%
485,554,000519,571,000533,036,000555,931,000666,710,000839,683,0001,180,046,0001,100,848,0001,773,341,0001,459,407,0001,557,200,0001,963,444,0001,907,449,0001,771,640,0002,072,355,0001,979,028,0001,930,876,0001,564,570,0002,059,031,0002,022,038,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
IPO date
Oct 31, 1995
Employees
70,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT